Mayo Clinic Cardiovascular CME Mayo Clinic

How Can Genetics Help in the Management of Heart Failure?
Guest: Naveen L. Pereira, M.D.
Hosts: Paul A. Friedman, M.D.
Cardiomyopathy is an important cause of heart failure and can be inherited or have a genetic basis. Identifying a genetic cause for cardiomyopathy not only provides a molecular diagnosis of the disease but holds significant importance in screening family members enabling early identification of disease, providing prognostic information to the patient and increasingly offers the opportunity for therapy that is genetic based. Understanding the genetics of cardiomyopathy also helps identify new pathophysiologic mechanisms of disease that may help in the development of new therapeutic targets.
 
Topics Discussed:
Genetic Testing as a tool to determine inherited cardiomyopathy
The yield of genetic testing for cardiomyopathy
What results can be expected after genetic testing is performed?

Can genetics provide new insight into the pathophysiology of disease, specifically cardiomyopathies?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

TRIO Score and Choosing Patients Most Likely to Benefit From Tricuspid Valve Intervention
Guest: Sorin V. Pislaru, M.D., Ph.D.
Hosts: Sharonne N. Hayes, M.D.
Tricuspid Regurgitation (TR) is an extraordinarily heterogeneous, highly prevalent valvular heart disease. Given the tremendous variability, individualizing risk in patients with TR to guide appropriate therapy will be explored. Other topics discussed will be the use of TRIO scores, GDMT as a first line in therapy, as well as when to consider surgery or percutaneous interventions.
 
Topics Discussed:
Is TR a relevant valvular heart disease?
Why the need for a risk score?
So what is the TRIO score
What else did you learn from the score?
The future?
 
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Deep-Learning Models for the Prognostication and Localization of Premature Ventricular Contractions Using a 12-Lead Electrocardiogram
Guest: Guru G. Kowlgi, M.B.B.S.

Host: Anthony H. Kashou, M.D. 
 
In this episode, learners will understand what premature ventricular contractions are. They will learn to differentiate benign rom malignant PVCs, and understand which patients are at risk for PVC-cardiomyopathy. Furthermore, they will gain knowledge about the traditional and novel tools for risk-stratifying patients with PVCs, and how we manage these patients.
 

Topics Discussed
What are PVCs and what are their clinical implications?
When should we be concerned about a patient with PVCs?
What are some of the tools we have to detect and localize high risk PVCs? How does AI help in this regard?
What are the available treatment modalities for managing PVCs?

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

How to Integrate NON-Statin Therapy in Your Practice. Updates from the Latest 2022 LDL-Cholesterol Lowering Guidelines
Guest: Regis I. Fernandes, M.D.
Hosts: Sharonne N. Hayes, M.D.
Since the last ACC/AHA cholesterol guidelines in 2018, the FDA has approved new non-statin cholesterol medications, which have increased our ability to provide a broader range of lipid-lowering drugs. In this podcast, we will discuss the new 2022 ACC expert consensus decision pathway on the role of non-statin therapies for LDL lowering in managing atherosclerotic cardiovascular disease risk. We will review these new drugs and discuss which ones to consider, when, and in what order.
 
Topics Discussed:

What are these new FDA-approved nonstatin drugs for lipid-lowering?


To whom and when non-statins should be considered?


Are there new LDL targets or thresholds for certain patients?

What are the new guideline recommendations for patients with statin intolerance?
 
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Lifetime Strategy in the Management of Aortic Stenosis
Guest: Mackram F. Eleid, M.D. and Kevin L. Greason, M.D.
Hosts: Patricia A. Pellikka, M.D.
This topic will discuss advances in the treatment of aortic stenosis, particularly with transcatheter aortic valve replacement. Strategies to manage aortic valve disease over a patient’s lifespan will be discussed, including topics of valve in valve, choice of prosthesis type, and commissural alignment.
 
Topics Discussed:
How has treatment of aortic stenosis changed in the last 10 years?
What are some of the challenging decisions physicians and patients make when deciding about treatment of aortic stenosis?
Explain the concept of commisural alignment - how important is it?
What is the longevity of TAVR valves and what treatments are available if they fail?
 
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.

Reop Sternotomy - How Many is too Many?
Guest: Joseph A. Dearani, M.D. and Elizabeth H. Stephens, M.D., Ph.D.
Hosts: Patricia A. Pellikka, M.D.
Reoperations are inevitable for many structural heart lesions, and in some cases, it may be multiple reoperations over a lifetime. Current techniques in perioperative imaging and contemporary surgical techniques make cardiac reoperations safe in most circumstances. Lifelong surveillance with a heart team approach of both cardiology and cardiac surgery is the optimal strategy to determine the proper timing of reoperation to achieve a good outcome.
 
Topics Discussed:
How many reoperations can a patient have?
What are the most common reasons for the need for reoperation?
Is it true that the risk of reoperation is often the same as a first-time operation?
What matters most with patient selection for reoperation?
Can a minimally invasive approach be applied at a reoperation?
Is the length of hospital stay and postoperative recovery different with reoperation?
Do all surgeons do cardiac reoperations?
 
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.